Treatment

MAVENCLAD 10 mg tablets clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic use (Phase IV)
Effects of CLADribine tablets on the Immune Synapse, in Relapsing Multiple Sclerosis (RMS) patients_CLADIS.
This study looks at how a medicine called MAVENCLAD affects the body's defence system in people with a type of multiple sclerosis. Researchers want to see if it changes how immune cells communicate and how this affects their MS over one year.
For: Multiple Sclerosis
Greece